SCHEMBL2441668

SCHEMBL2441668

CCOC(=O)C=C1CCc2cc3ccc(OCc4ccccc4)cc3n21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HSP90AA1 P07900 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
SRD5A2 P31213 1/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PPARG P37231 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
ALDH1A1 P00352 1/20 0.40
ACSS2 Q9NR19 1/20 0.39
NMT2 O60551 1/20 0.39
NMT1 P30419 1/20 0.39
ALOX5 P09917 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
S1PR1 P21453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016774 0.88 ALOX5 (0.44) MAOBMEN1KMT2ASRD5A2NPC1
SCHEMBL2447545 0.87 SRD5A2 (0.43) MAOBMEN1KMT2ASRD5A2NPC1
SCHEMBL2021908 0.76 NOTUM (0.55) MAOBMEN1KMT2ASRD5A2NPC1
SCHEMBL2021478 0.74 SRD5A2 (0.43) MAOBMEN1KMT2ASRD5A2L3MBTL1
Potassium Ion SCHEMBL2447150 0.74 MAOB (0.47) MAOBMEN1KMT2AHSP90AA1NR1H4
SCHEMBL2441664 0.72 SRD5A2 (0.47) MAOBMEN1KMT2AHSP90AA1NR1H4
SCHEMBL2441665 0.72 SRD5A2 (0.47) MAOBMEN1KMT2AHSP90AA1NR1H4
SCHEMBL3966171 0.71 MAOB (0.51) MAOBMEN1KMT2AHSP90AA1NR1H4
SCHEMBL3966174 0.71 MAOB (0.51) MAOBMEN1KMT2AHSP90AA1NR1H4
SCHEMBL2018948 0.70 SRD5A2 (0.46) MAOBMEN1KMT2AHSP90AA1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542554-A1 PROCESSES FOR THE PREPARATION OF S1P1 RECEPTOR MODULATORS AND CRYSTALLINE FORMS THEREOF Arena Pharmaceuticals, Inc. (US) 2013-01-09 EP disclosed
WO-2011109471-A1 PROCESSES FOR THE PREPARATION OF S1P1 RECEPTOR MODULATORS AND CRYSTALLINE FORMS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2011-09-09 WO disclosed